Generic Drugs Market Research Reports

U.S. Specialty Injectable Generics Market Analysis By Therapeutic Use (Oncology, Cardiovascular, Central Nervous System, Infectious Diseases, Autoimmune Disorders), And Segment Forecasts, 2014 - 2025 - Product Thumbnail Image

U.S. Specialty Injectable Generics Market Analysis By Therapeutic Use (Oncology, Cardiovascular, Central Nervous System, Infectious Diseases, Autoimmune Disorders), And Segment Forecasts, 2014 - 2025

  • Report
  • 76 Pages
From
US Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023 - Product Thumbnail Image

US Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023

  • Report
  • 84 Pages
From
Specialty Generics Market Analysis By Type, By End-use, And Segment Forecasts, 2014 - 2025 - Product Thumbnail Image

Specialty Generics Market Analysis By Type, By End-use, And Segment Forecasts, 2014 - 2025

  • Report
  • 101 Pages
From
Global Viral Infections Market to 2021 - Promising New Competitors and Expanding Treatment Population to Offset Increased Uptake of Generics - Product Thumbnail Image

Global Viral Infections Market to 2021 - Promising New Competitors and Expanding Treatment Population to Offset Increased Uptake of Generics

  • Report
  • 179 Pages
From
The Future of Generic Drugs and Strategies for Commercial Success - Product Thumbnail Image

The Future of Generic Drugs and Strategies for Commercial Success

  • Report
  • 83 Pages
From
Global Markets for Generic Drugs - Product Thumbnail Image

Global Markets for Generic Drugs

  • Report
  • 155 Pages
From
New Generics 2015-2020 - Product Thumbnail Image

New Generics 2015-2020

  • Report
  • 111 Pages
From
Understanding Pain Management and Opioids: FDA Regulations, Generics and Recent Approvals - Webinar - Product Thumbnail Image

Understanding Pain Management and Opioids: FDA Regulations, Generics and Recent Approvals - Webinar

  • Webinar
Generic and Biosimilar Pharmaceuticals (GLOBAL) - Industry Report - Product Thumbnail Image

Generic and Biosimilar Pharmaceuticals (GLOBAL) - Industry Report

  • Report
  • 1410 Pages
From
Understanding ANDAs and Paragraph IV Patent Certifications - Webinar - Product Thumbnail Image

Understanding ANDAs and Paragraph IV Patent Certifications - Webinar

  • Webinar
Global Generics Industry Profile & Value Chain Analysis - Product Thumbnail Image

Global Generics Industry Profile & Value Chain Analysis

  • Report
  • 45 Pages
From
Generic Pharmaceutical Manufacturing in the US - Industry Market Research Report - Product Thumbnail Image

Generic Pharmaceutical Manufacturing in the US - Industry Market Research Report

  • Report
  • 42 Pages
From
Generics Global Industry Guide 2017-2021 - Product Thumbnail Image

Generics Global Industry Guide 2017-2021

  • Report
  • 247 Pages
From
Generics Top 5 Emerging Markets Industry Guide 2017-2021 - Product Thumbnail Image

Generics Top 5 Emerging Markets Industry Guide 2017-2021

  • Report
  • 124 Pages
From
Generics BRIC (Brazil, Russia, India, China) Industry Guide 2017-2021 - Product Thumbnail Image

Generics BRIC (Brazil, Russia, India, China) Industry Guide 2017-2021

  • Report
  • 110 Pages
From
Generics North America (NAFTA) Industry Guide 2017-2021 - Product Thumbnail Image

Generics North America (NAFTA) Industry Guide 2017-2021

  • Report
  • 66 Pages
From
Generics Global Group of Eight (G8) Industry Guide 2017-2021 - Product Thumbnail Image

Generics Global Group of Eight (G8) Industry Guide 2017-2021

  • Report
  • 163 Pages
From
Generics Global Industry Almanac 2017-2021 - Product Thumbnail Image

Generics Global Industry Almanac 2017-2021

  • Report
  • 449 Pages
From
Important Para IV Events - Product Thumbnail Image

Important Para IV Events

  • Report
The 2019-2024 World Outlook for Generic Inhalation and Nasal Spray Drugs - Product Thumbnail Image

The 2019-2024 World Outlook for Generic Inhalation and Nasal Spray Drugs

  • Report
  • 270 Pages
Loading Indicator

The global generics market is fast growing, driven by demand for cost-effective medicines and new availability of high value products. By now there are 17 generic companies with revenues in excess of US$1 billion, while there were only 12 in 2008/09.

The reports, books, and subscriptions listed under Research and Markets’ Generic Drugs category cover every aspect of this industry, such as market trends, forecasts, drivers and restraints, etc. They will allow you to identify business opportunities and assess the strategies of the major players. You can also investigate the latest international and national patent opportunities across a vast number of INNs (international non-proprietary names), taking into account key concerns such as expiry dates, national regulations, etc.

Key players featured in our publications includes Teva Pharmaceutical, Mylan, Sandoz, Watson Pharmaceuticals, Greenstone, Par Pharma, Hospira, Apotex, Mallinckrodt, Dr. Reddy's, and more. Show Less
Read more

adroll